Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2025-12-24 @ 2:41 PM
NCT ID:
NCT02829359
Eligibility Criteria:
Inclusion Criteria:
* underwent initial hepatectomy;
* preoperative serum HBsAg positive
* serum HBV DNA negative
* serum ALT in normal range
* Child-Pugh A liver function
* HCC was confirmed by histopathology
* patients in the treated group received Entecavir (ENT) while patients in the control group did not receive any antiviral therapy.
Exclusion Criteria:
* underwent preoperative TACE or other anti-tumor treatments
* underwent preoperative antiviral treatment for nearly a year
* with autoimmune disease, other organ malignant tumor, or other severe disease.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02829359
Study Brief:
Protocol Section:
NCT02829359